In this E-Book we discuss:
More about this E-Book
Engineered T cells hold immense potential for immunotherapy, and there are many ways to amend or create immunotherapies using gene editing.
New methods of characterizing gene-edited cells need to be implemented to accelerate therapeutic efficacy and outcomes, such as potency and reducing immune-related adverse events.
Download this eBook to learn how IsoPlexis’ Functional Proteomics is changing genome editing & engineering for cell immunotherapy.